SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-165156
Filing Date
2022-06-01
Accepted
2022-06-01 16:06:27
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 d322267ds3.htm S-3 400991
2 EX-1.2 d322267dex12.htm EX-1.2 222886
3 EX-4.3 d322267dex43.htm EX-4.3 33722
4 EX-4.4 d322267dex44.htm EX-4.4 248379
5 EX-5.1 d322267dex51.htm EX-5.1 34662
6 EX-23.1 d322267dex231.htm EX-23.1 1728
7 EX-FILING FEES d322267dexfilingfees.htm EX-FILING FEES 26954
8 GRAPHIC g322267g44m16.jpg GRAPHIC 41231
9 GRAPHIC g322267g44m17.jpg GRAPHIC 41202
10 GRAPHIC g322267g44m18.jpg GRAPHIC 41204
11 GRAPHIC g322267g44m19.jpg GRAPHIC 41216
12 GRAPHIC g322267snap0005.jpg GRAPHIC 9576
  Complete submission text file 0001193125-22-165156.txt   1185555
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-265346 | Film No.: 22987358
SIC: 2834 Pharmaceutical Preparations